Caliper Life Sciences (CALP) Tops Q1 EPS by 3c, Posts Q2 and FY11 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CALP Hot Sheet
Price: $10.49 --0%
Financial Fact:
License fees and contract revenue: 3.92M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
License fees and contract revenue: 3.92M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Caliper Life Sciences (NASDAQ: CALP) reported Q1 EPS of $0.01, $0.03 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $35.8 million versus the consensus estimate of $33.46 million.
Caliper Life Sciences sees FY2011 GAAP revenue of $138-$146 million, versus the consensus of $141.3 million.
Caliper Life Sciences sees Q2 2011 GAAP revenue of $33-$36 million, versus the consensus of $33.96 million.
Caliper Life Sciences sees FY2011 GAAP revenue of $138-$146 million, versus the consensus of $141.3 million.
Caliper Life Sciences sees Q2 2011 GAAP revenue of $33-$36 million, versus the consensus of $33.96 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
